Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Hematology

Symptoms, Complications, and Warning Signs

At a Glance

CDA I can cause fatigue, jaundice, an enlarged liver or spleen, iron overload, gallstones, and problems involving the heart, lungs, bones, or hormones. Know your usual baseline and seek emergency help for severe breathing trouble, fainting, confusion, clot symptoms, or fever after spleen removal.

While the core of Congenital Dyserythropoietic Anemia Type I (CDA I) is the failure of the bone marrow to produce healthy red blood cells, the condition affects more than just your blood counts. Because red blood cells carry oxygen to every part of your body, the symptoms and complications of CDA I can involve the liver, heart, lungs, and bones [1][2].

Understanding what is “routine” for you or your child versus what requires medical attention is a vital part of managing this ultra-rare condition.

Common Symptoms at Presentation

CDA I can be discovered at any age, from before birth to late adulthood. The symptoms often depend on when the condition first appears.

  • Anemia and Fatigue: This is the most common feature. You may experience persistent tiredness, pale skin (pallor), or a lack of energy [3].
  • Jaundice: A yellowing of the skin and the whites of the eyes is common because the body is constantly breaking down abnormal red blood cells [1].
  • Organ Enlargement: The liver and spleen often work overtime to filter out abnormal red blood cells, which can cause them to become enlarged (hepatosplenomegaly) [4].
  • Early Onset: In newborns, CDA I may present as severe jaundice or a condition called cholestasis, where bile flow from the liver is reduced [5].

Long-Term Complications

Even if the anemia itself is mild, CDA I requires lifelong monitoring because of how it affects other organs over time. Please note that several statistics below come from small cohorts of adults referred to specialist centers, and may not represent the exact probability for a child or mildly affected person today.

Iron Overload

The most significant long-term risk in CDA I is iron overload. Crucially, this can happen even if you have never received a blood transfusion [6]. In one MRI study of 46 patients, over 60% of patients had mild-to-moderate iron buildup in their liver [6]. Because the body thinks it is low on iron (due to the anemia), it absorbs more from food, which then accumulates in the liver and other organs [1].

Gallstones

Because red blood cells are broken down more quickly than normal, the body produces high levels of bilirubin. This can lead to the formation of gallstones (cholelithiasis). In a small cohort of adults with CDA I, 70% were found to have gallstones [2].

Pulmonary and Heart Health

  • Pulmonary Arterial Hypertension (PAH): This is high blood pressure in the arteries of the lungs. It was reported in about 24% of adults in one clinical study and can lead to shortness of breath and heart strain [2].
  • Heart Structure: Some patients may have a structural variation called left-ventricular hypertrabeculation, where the heart muscle appears “spongy,” though this often does not affect how well the heart pumps [7].

Bone and Endocrine Issues

The “overactive” bone marrow can sometimes affect the surrounding bone. Complications may include:

  • Low Bone Density: Osteoporosis and low bone density have been reported frequently in adult cohorts [2].
  • Endocrine Disorders: Iron buildup can damage the glands that produce hormones, leading to hypothyroidism (underactive thyroid) or diabetes mellitus [2].
  • Skeletal Anomalies: While rare, some children may be born with physical differences like short stature, hip dysplasia, or limb anomalies [8].

Urgent Warning Signs and Action Plans

In CDA I, it is normal to feel tired or look slightly yellowed. These are “baseline” symptoms. However, certain signs indicate a medical situation that requires evaluation.

Seek IMMEDIATE emergency medical care if you experience:

  • Severe Hypoxia (Low Oxygen): Sudden, extreme shortness of breath, a blue tint to the lips or fingernails, or fainting [9].
  • Signs of Organ Failure: Sudden confusion/disorientation, bleeding, severe vomiting, or marked weakness [10][11].
  • Signs of a Blood Clot: Sudden swelling, pain, or redness in one leg (a Deep Vein Thrombosis), or sudden chest pain and trouble breathing [12].
  • Fever Without a Spleen: If you have had your spleen removed (splenectomy), any fever (typically a temperature of at least 38.0°C/100.4°F) is a medical emergency requiring immediate assessment and antibiotics [2].
  • Crisis in Infants: If a baby with CDA I becomes extremely fussy, refuses to eat, or has a rapidly swelling abdomen, they need immediate assessment [9].

Contact your clinician for same-day assessment if you experience:

  • Acute Jaundice or Gallbladder Issues: Persistent pain in the upper right side of the abdomen with vomiting or fever, or rapidly worsening jaundice (skin turning much darker yellow) or dark urine.
  • Worsening Anemia: A severe, unexplained drop in energy levels beyond your usual fatigue.

Note on Splenectomy: Removing the spleen does not correct the underlying ineffective erythropoiesis. If you have had a splenectomy, you are at a higher risk for severe infections (sepsis) and potentially blood clots or pulmonary hypertension. You must have a strict prevention plan: ensure you receive pneumococcal, meningococcal, and Haemophilus influenzae type b vaccines; discuss antibiotic prophylaxis with your doctor; and wear medical-alert identification [2][12].

Common questions in this guide

Which symptoms are common in congenital dyserythropoietic anemia type I?
Common symptoms include anemia-related fatigue, pale skin, jaundice, and an enlarged liver or spleen. Newborns may have severe jaundice or cholestasis, which means reduced bile flow from the liver.
Can CDA I cause iron overload if I have never had a transfusion?
Yes. Ineffective red blood cell production can signal the body to absorb more iron from food, allowing iron to build up in the liver and other organs even without a history of blood transfusions. Clinicians may monitor liver iron with an MRI T2* scan.
What long-term health problems can CDA I cause?
Possible complications include iron overload, gallstones, high blood pressure in the lung arteries, low bone density, thyroid or blood-sugar problems, and some heart or skeletal changes. The frequency and severity vary, and some reported statistics come from small studies of adults treated at specialist centers.
Which symptoms mean CDA I needs emergency care?
Get emergency help for sudden severe shortness of breath, blue lips or fingernails, fainting, confusion, bleeding, severe vomiting, marked weakness, or symptoms of a blood clot. After spleen removal, a fever of 38.0°C (100.4°F) or higher is an emergency because of the risk of severe infection.
How does spleen removal change health risks in CDA I?
Removing the spleen does not correct the underlying red blood cell production problem and can increase the risk of severe infection, blood clots, and pulmonary hypertension. Ask your clinician about recommended vaccines, antibiotic prevention, and medical-alert identification.
What monitoring tests are used to watch for CDA I complications?
Monitoring may include baseline hemoglobin and bilirubin, MRI T2* scans for liver iron, echocardiograms for pulmonary arterial hypertension, and screening of bone density, thyroid function, and blood sugar. Your clinician can set the schedule based on your health history and symptoms.

Get notified when new evidence is published on Congenital dyserythropoietic anemia type I.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.

    Meznarich JA, Draper L, Christensen RD, et al.

    Blood cells, molecules & diseases 2018; (71()):63-66 doi:10.1016/j.bcmd.2018.03.002.

    PMID: 29599085
  2. 2

    Morbidity and mortality of adult patients with congenital dyserythropoietic anemia type I.

    Shalev H, Al-Athamen K, Levi I, et al.

    European journal of haematology 2017; (98(1)):13-18 doi:10.1111/ejh.12778.

    PMID: 27206021
  3. 3

    Double Heterozygous CDAN1 Variants of Uncertain Significance Associated With a Phenotype Consistent With Congenital Dyserythropoietic Anemia Type 1.

    Zablonski KG, Lachant NA, Perkins A, Archibald WJ

    Case reports in hematology 2026; (2026()):8073716 doi:10.1155/crh/8073716.

    PMID: 42682828
  4. 4

    [Whole exome sequencing analysis of compound heterozygous variants of CDAN1 gene in a Chinese family with non-immune hydrops fetalis].

    Wang Y, Li Q, Sun X, et al.

    Nan fang yi ke da xue xue bao = Journal of Southern Medical University 2021; (41(12)):1899-1903 doi:10.12122/j.issn.1673-4254.2021.12.21.

    PMID: 35012925
  5. 5

    Neonatal cholestasis and hepatosplenomegaly caused by congenital dyserythropoietic anemia type 1: A case report.

    Jaramillo C, Ermarth AK, Putnam AR, Deneau M

    World journal of hepatology 2019; (11(5)):477-482 doi:10.4254/wjh.v11.i5.477.

    PMID: 31183007
  6. 6

    Hepatic and cardiac iron load as determined by MRI T2* in patients with congenital dyserythropoietic anemia type I.

    Asleh M, Levitas A, Daniel S, et al.

    Annals of hematology 2020; (99(11)):2507-2512 doi:10.1007/s00277-020-04263-4.

    PMID: 32918595
  7. 7

    Prevalence of left ventricular hypertrabeculation/noncompaction among patients with congenital dyserythropoietic anemia Type 1 (CDA1).

    Abramovich-Yoffe H, Shalev A, Barrett O, et al.

    International journal of cardiology 2020; (317()):96-102 doi:10.1016/j.ijcard.2020.05.092.

    PMID: 32512057
  8. 8

    Successful management of transfusion-dependent congenital dyserythropoietic anemia type 1b with interferon alfa-2a.

    Rathe M, Møller MB, Greisen PW, Fisker N

    Pediatric blood & cancer 2018; (65(3)) doi:10.1002/pbc.26866.

    PMID: 29049846
  9. 9

    Severe Neonatal Anemia with Multi-Organ Failure, Extreme Placentomegaly, and Placental Megaloblastic Erythroblastosis as Features in Identifying Congenital Dyserythropoietic Anemia Type 1: A Case Report.

    Roose O, Gengler C, Stoykova S, et al.

    Neonatology 2025; (122(5)):557-560 doi:10.1159/000546794.

    PMID: 40472828
  10. 10

    Fetal-onset Congenital Dyserythropoietic Anemia Type 1 due to a Novel Mutation With Severe Iron Overload and Severe Cholestatic Liver Disease.

    Chin HL, Lee LY, Koh PL

    Journal of pediatric hematology/oncology 2019; (41(1)):e51-e53 doi:10.1097/MPH.0000000000001151.

    PMID: 29668551
  11. 11

    Acute Liver Failure in a Pediatric Patient with Congenital Dysery-Thropoietic Anemia Type I Treated with Deferasirox.

    Ling G, Pinsk V, Golan-Tripto I, Ling E

    Hematology reports 2015; (7(3)):5987 doi:10.4081/hr.2015.5987.

    PMID: 26487935
  12. 12

    Increased Prevalence of Thromboembolic Events in Patients with Congenital Dyserythropoietic Anemia Type I.

    Asleh M, Khalaila A, Eshel Y, et al.

    Acta haematologica 2026; (149(3)):345-354 doi:10.1159/000547577.

    PMID: 40738024

This page about CDA I symptoms and warning signs is for informational purposes only and does not constitute medical advice. Seek urgent care for emergency symptoms and ask your hematology team how to respond to changes from your usual baseline.